Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A congenital vascular disorder characterized byan abnormal connection between an artery and a vein, appearing as varicose veins with port wine discoloration, leading to a bypass of the capillary bed. Signs and symptoms include palpable continuous thrill in the dilated vessels, continuous machinery murmur with systolic accentuation, collapsing arterial pulse, Nicoladoni Branham sign, as well as local gigantism and hot ulcers due to hypoxia, among others.
Biomarker and diagnostic research for congenital arteriovenous fistula has been reported in the published literature.
No approved treatments are currently available for congenital arteriovenous fistula. An additional 1 compound holds orphan drug designation.
While no drugs are FDA-approved specifically for congenital arteriovenous fistula, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.
The following drugs have received orphan drug designation from the FDA for congenital arteriovenous fistula. Orphan designation reflects regulatory interest and does not indicate approval for treatment.
Brand Name | Generic Name | Sponsor |
|---|
No clinical trials have been registered for congenital arteriovenous fistula.
39 publications have been identified in PubMed for congenital arteriovenous fistula. Research spans Case Report / Case Series (59%), Review / Meta-Analysis (16%), and Clinical Trial Publication (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 22 | 59% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:42 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about congenital arteriovenous fistula
Designated
Exclusivity End |
|---|
Designation Status |
|---|
vonapanitase | vonapanitase | Proteon Therapeutics, Inc. | 2009 | — | Designated |
View trials for congenital arteriovenous fistula
Research summaries
6 |
16% |
Clinical study results | 4 | 11% |
Testing and diagnosis research | 2 | 5% |
Disease patterns and progression | 2 | 5% |
Laboratory research | 1 | 3% |
Kaneko N (2026). [PMID: 41317163](https://pubmed.ncbi.nlm.nih.gov/41317163/). *JACC Case Rep*. [Clinical Trial Publication]
Ponce-Rivera MS (2026). [PMID: 40401415](https://pubmed.ncbi.nlm.nih.gov/40401415/). *Vascular*. [Epidemiology / Natural History]
Goncalves BKD (2026). [PMID: 42025900](https://pubmed.ncbi.nlm.nih.gov/42025900/). *Am J Cardiol*. [Case Report / Case Series]
Huang C (2026). [PMID: 41815897](https://pubmed.ncbi.nlm.nih.gov/41815897/). *Front Cardiovasc Med*. [Case Report / Case Series]
Mini N (2026). [PMID: 42051434](https://pubmed.ncbi.nlm.nih.gov/42051434/). *Front Cardiovasc Med*. [Clinical Trial Publication]
Viglione M (2026). [PMID: 39108035](https://pubmed.ncbi.nlm.nih.gov/39108035/). *J Endovasc Ther*. [Review / Meta-Analysis]
Al Qaraghuli A (2026). [PMID: 41973884](https://pubmed.ncbi.nlm.nih.gov/41973884/). *JACC Case Rep*. [Case Report / Case Series]
Li W (2025). [PMID: 39991454](https://pubmed.ncbi.nlm.nih.gov/39991454/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Behrend L (2025). [PMID: 41001516](https://pubmed.ncbi.nlm.nih.gov/41001516/). *Int J Cardiol Congenit Heart Dis*. [Epidemiology / Natural History]
Shinohara T (2025). [PMID: 39723537](https://pubmed.ncbi.nlm.nih.gov/39723537/). *Arterioscler Thromb Vasc Biol*. [Basic Science / Preclinical]
AI-curated news mentioning congenital arteriovenous fistula
Updated Apr 10, 2026
A recent study details the endovascular repair of significant twin aneurysms in the renal artery and vein linked by an arteriovenous fistula. This research contributes to the understanding of complex vascular anomalies and potential treatment strategies.
A recent study details the endovascular repair of an ilio-iliac arteriovenous fistula, which presented as acute lower limb edema. This research contributes to the understanding of vascular complications and their management.